Biotech Week articles from August 2002

Biotech Week archives from August 2002

Novel cancer vaccines report presented at Therapeutic Vaccines European Congress 2002.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM) (BRA) announced that a Biomira company representative presented at the Therapeutic Vaccine European Congress 2002, London, England. The Congress focused on therapeutic vaccines...

Invasive pneumococcal disease more prevalent in England/Wales than reported.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - The true incidence of invasive pneumococcal disease (IPD) incidence in England and Wales is at least three times the official estimate, according to...

Ribosomal protein mutation confers staphylococcal quinupristin resistance.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in France have elucidated the mechanisms of quinupristin resistance in refractory Staphylococcus aureus strains. Brigitte Malbruny and...

Program ends alcohol, cocaine abuse.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- CITA Biomedical, Inc., a growing leader in the treatment of substance dependency, announced that two major California medical centers will begin using its advanced therapeutic program to treat patients...

Phase III clinical trial of Actiza initiated.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Connetics Corporation (CNCT), a specialty pharmaceutical company focused on the development and commercialization of dermatology products, announced the initiation of its phase III clinical program for...

ATP-dependent drug removal can contribute to viral resistance.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - With the help of adenosine triphosphate (ATP), a key HIV enzyme can repel agents used to inhibit it, researchers in the United States report. "Removal of...

Lorus, NCI to collaborate on multiple phase II clinical trials of GTI-2040.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Lorus Therapeutics, Inc., announced that they have been approved by the drug development group of the division of cancer treatment and diagnosis, National Cancer Institute (NCI), to supply their lead...

Novel selective T-cell depletion method may reduce graft-versus-host disease risk.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Canada have developed a novel technique for selectively destroying activated T-cells, which they say could help prevent graft-versus-host disease...

Suit filed on behalf of purchasers of securities.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- On June 24, 2002, the law firm of Berger & Montague, P.C. filed a class action suit against Applied Digital Solutions, Inc., (ADSXE) and its CEO, who is also a director, in the United States District...

PharmaKinetics signs definitive merger agreement.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- PharmaKinetics Laboratories, Inc., (PKLB) announced that it has signed a definitive agreement of merger with Bioanalytical Systems, Inc. (BASI). The merger agreement provides for a merger of...

Record sales results in increase in profitability.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Biolase Technology, Inc., (BLTI), a medical technology company focused on pain-free medical and dental procedures, confirmed that the company will report record sales for the second quarter and 6 months...

Second round financing closed at over EURO 5M.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Biopsytec Holding AG, one of the leading European companies in molecular biology applications for agriculture, has announced the raising of over EURO 5 million in a second round of financing. The...

Class-based profiling added to ClassPharmer Screening Analysis Suite.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Bioreason, Inc., has released the ClassPharmer Suite of software solutions for automating screening data analysis. Available for download via the web, the newest release brings the number of modules...

New director of U.S. sales, marketing named.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Bioreason, Inc., announced that Peter Grant has joined its staff as senior director of sales and marketing for the U.S. Grant brings senior sales experience from the cheminformatics and laboratory...

Tender offer for BEI Medical Systems completed.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) and BEI Medical Systems Company, Inc., (BMED) announced the successful completion of Boston Scientific's tender offer for all of the issued and outstanding shares of...

Three new executives added to senior management.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Bradley Pharmaceuticals, Inc., (BPRX), announced the addition of three new members to the senior management team. H. Jurgen van den Woldenberg has joined the company as executive vice president,...

Andrew Bonfield named senior vice president, chief financial officer.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb Company (BMY) announced the appointment of Andrew R.J. Bonfield as senior vice president and chief financial officer. Bonfield served most recently as executive director of...

Raw materials awarded 'certified organic' rating.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Carrington Laboratories, Inc., (CARN) reported that material grown and refined at its Costa Rica facility, Finca Sabila, has been awarded the "certified organic" designation by Costa Rica's Eco-LOGICA....

Clinical development program expanded for Revimid.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Celgene Corporation (CELG) announced the initiation of five additional trials of Revimid (CC-5013) in hematological and solid tumor cancers. The trials, conducted in partnership with the Comprehensive...

U.S. patent granted for use of potassium channel openers.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Cellegy Pharmaceuticals, Inc., (CLGY) announced that the United States Patent and Trademark Office (USPTO) has issued a patent (U.S. No. 6,395,736) that covers methods of treating anorectal disorders by...

TransTech Pharma enters drug discovery collaboration.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- TransTech Pharma, Inc., and Cephalon, Inc., (CEPH) announced a multiyear research collaboration using TransTech's proprietary Translational Technology to discover and develop small molecules for up to...

Digene terminates merger agreement.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Digene Corporation (DIGE) announced that on Sunday, June 30, 2002, Digene delivered to Cytyc Corporation (CYTC) formal notice of Digene's termination of the Merger Agreement dated February 19, 2002,...

EXACT Sciences, LabCorp partner on PreGen-Plus for early cancer detection.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- EXACT Sciences Corporation (EXAS) and Laboratory Corporation of America Holdings (LH) (LabCorp) announced the creation of an exclusive, long-term strategic partnership to commercialize PreGen-Plus,...

Scott Chappel named to board of directors.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- EmerGen, Inc., announced the appointment of Scott C. Chappel, PhD, to its board of directors. Chappel is currently executive vice president, research and technology of Dyax, Inc., a biotechnology...

Buyback program authorized.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Endocare, Inc., (ENDO), a developer of innovative diagnostic and treatment tools for cancer and other diseases, announced that its board of directors has authorized the repurchase of up to 1 million...

Endocare completes purchase of cryoablation business.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Endocare, Inc., (ENDO), a developer of innovative diagnostic and treatment tools for cancer and other diseases, announced that it has completed the purchase of the cryosurgical business line and assets...

Common stock repurchase announced.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Endovasc, Ltd., Inc., (ENDV; ED7) reports that it intends to make open market purchases of up to 2% of its common stock pursuant to SEC Rule 10b-18 of the Securities Exchange Act of 1934. "Recent...

Voting results from reconvened annual meeting announced.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- EntreMed, Inc., (ENMD), a biopharmaceutical leader in angiogenesis research and product development, announced that it reconvened its annual meeting of stockholders, which was adjourned on June 6, 2002....

Genset continues suspension of trading.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Genset S.A. confirmed that discussions concerning a possible major strategic transaction continue. The preliminary discussions contemplate that a third party would offer to acquire all the ordinary...

Sroufe and Palmer join senior management team.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Helix BioMedix, Inc., (HXBM) an early stage biotechnology company, announced that Parker Sroufe and Kerry Palmer joined its senior management team on June 1, 2002. Sroufe is filling the newly...

Trinity announces amendment of Remune supply contracts.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Trinity Medical Group USA, Inc., (TMGU) announced that it has amended its Remune license and collaboration contract with the Immune Response Corp. (IMNR). The amended contract provides for an...

Lester J. Kaplan, PhD, appointed to board of directors.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Medinox, Inc., announced that Lester J. Kaplan, PhD, president of R&D and global Botox, and board member of Allergan, Inc., has been appointed to its board of directors. Kaplan brings extensive...

Keith Powell named executive VP.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Nautilus announced the appointment of Keith Powell as executive vice president of Nautilus Biotech USA in charge of Nautilus' corporate business development. Since October 1999, Dr. Keith Powell,...

Nasdaq compliance date announced.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- NeoTherapeutics, Inc., (NEOT) announced that Nasdaq has notified the company that it is not in compliance with Nasdaq's minimum bid price per share ($1.00) requirements for continued listing on the...

Norak and Q3DM, Inc., announce collaboration for screening of GPCRs.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Norak Biosciences, Inc., and Q3DM, Inc., (Q3DM) announced the signing of a collaborative agreement to enable biotechnology and pharmaceutical companies involved in drug discovery to study G...

Wayne L. Pines becomes new director.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Northwest Biotherapeutics, Inc., (NWBT) announced that its board of directors has appointed Wayne L. Pines as a director effective June 20, 2002. Pines, a former associate commissioner of the U.S....

Company completes $15 million series B financing.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Odyssey Pharmaceuticals, Inc., a drug discovery company, announced it has closed a $15 million Series B financing. HBM Partners led the round, which included the company's Series A investor, Burrill &...

Oncolytics completes acquisition of interest in Transition Therapeutics.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Oncolytics Biotech, Inc., (ONCY) announced it has completed its acquisition of 6,890,000 common shares of Transition Therapeutics, Inc., (TTH) from existing shareholders of TTH, representing...

Pharmacopeia identifies compounds in lead discovery program.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Pharmacopeia, Inc., (PCOP) announced that it has achieved a milestone in its lead discovery collaboration with Organon. Pharmacopeia has identified a lead series of active compounds against an Organon...

Company withdraws $110 million universal shelf registration statement.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Pharmaceutical Resources, Inc., (PRX) announced that its board of directors has determined that it is in the best interests of the company and its shareholders to request the withdrawal of PRI's...

Company secures $2.75 million in staged financing.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- RxKinetix, Inc., announced that it has closed a $2.75 million private placement to fund the preclinical development and submission of an investigational new drug (IND) application for a new drug...

James E. Rurka named as president and CEO.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- SLIL Biomedical Corp. announced that James E. (Jim) Rurka has joined the company as president and CEO and a director. Additionally, the company announced that Dr. Bradley Brown has been named a...

CPMP recommends granting marketing authorization for Plavix/Iscover.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Sanofi-Synthelabo and Bristol-Myers Squibb Company (BMY) announced that the Committee for Proprietary Medicinal Products (CPMP) has adopted a positive opinion recommending to grant a marketing...

Company announces intention to list on the New York Stock Exchange.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Sanofi-Synthelabo announced that it intends to list on the New York Stock Exchange (NYSE). Sanofi-Synthelabo has entered into the documentation process with the Securities and Exchange Commission...

Drug discovery company completes $29 million new round of investment.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Drug discovery company Scynexis, Inc., announced it has successfully completed a $29 million round of financing from a syndicate of U.S. and European venture funds led by Alta Partners. Also...

Cash tender offer for Genset.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- As Serono S.A. (SEO, SRA) and Genset (GENXY) announced previously, and following the decision by Genset's shareholders to remove the provision in Genset's bylaws, which limited a shareholder's voting...

Safety data on novel cyclosporin presented.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Enanta Pharmaceuticals, Inc., presented data from preclinical toxicology and ADME (absorption, distribution, metabolism and excretion) studies of its novel cyclosporin softdrug analogs. Last...

Details of oral insulin studies presented at the Endocrine Society's annual meeting.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corporation (GNBT), a leader in the area of buccal drug delivery, reported the details of data from studies sponsored by the company and presented at The Endocrine Society's...

Court issues opinion in dispute.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced that the United States District Court for the Northern District of Illinois has issued a written opinion confirming its June 13 oral ruling in favor of...

Data demonstrate Actimid well tolerated, active.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Celgene Corporation (CELG) announced that investigators from Guy's Hospital in London presented interim data at the 31st Annual Meeting of the International Society for Experimental Hematology from an...

$1.2M clinical research contract set for phase IV study.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Covalent Group, Inc., (CVGR) announced the signing of a $1.2 million contract with one of the world's leading pharmaceutical companies. This phase IV trial is designed to expand the label of a...

New XRC option launched.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- GeneMachines announces the new XRC option for the high-throughput PolyPlex DNA synthesizer that will allow unattended 60-mer oligonucleotide synthesis. The unique design of the PolyPlex synthesizer...

Acquisition of Interbio expands company's enzymes business.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- On July 1, 2002, Novozymes took over the majority of the activities of InterBio, Texas. By acquiring the three largest companies in the sector, Novozymes says it has paved the way for a new...

SBIR/NIH/NIAID grant given for pathogen sensor development.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- BioForce Nanosciences, Inc., the leading developer of nanoarray biomolecular analysis systems, has been awarded a phase I SBIR/NIH/NIAID grant for developing an ultra-sensitive, ultra-miniaturized...

Zygogen Licenses RCFP for drug discovery.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Zygogen, LLC, announced that it has selected BD Biosciences Clontech's Reef Coral Fluorescent Proteins (RCFP) as the most optimal fluorescent markers for integration into its stable transgenic...

John M. Eisenberg selected for research prize.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- In recognition of his outstanding efforts to advance global health services research, John Eisenberg was awarded posthumously the prestigious 2002 Baxter International Foundation Health Services...

Early market research is essential for achieving pharmaceutical blockbuster success.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- World-class pharmaceutical companies know that blockbuster success depends on a well-executed market research plan that starts early in the product development process. Research and consulting...

Capers McDonald named entrepreneur of the year.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- BioReliance Corporation (BREL), a diversified contract service organization focused in biotechnology and pharmaceutical services, announced that Capers W. McDonald, president and CEO, has been named...

Biotech continues its downward spiral during Q2 02.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- The biotechnology industry has had an exceedingly disappointing second quarter of the year. Disarming headlines concerning ImClone (IMCL), Sam Waksal, insider trading, and the latest mega...

Federal court grants injunction in patent infringement case.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- CIBA Vision Corporation, the eye care unit of Novartis AG (NVS), announced that the United States District Court for the District of Delaware ruled in favor of the company's wholly owned subsidiary,...

Executive transition finalized.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Caliper Technologies Corp. (CALP) reported that the previously announced appointments of Michael R. Knapp, PhD as CEO and James L. Knighton as president were effective July 1. Daniel L. Kisner, MD,...

Company announces financial results.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- CardioTech International, Inc., (CTE) announced revenues of $3,220,000 for the year ended March 31, 2002, as compared with $1,543,000 for the same prior year period, an increase of $1,677,000 or 109%....

Centaur BioResearch changes name; effects reverse stock split.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Centaur BioResearch, Inc., (CUBO) announced that it has changed its name to Advanced Global Industries Corporation to reflect a new direction for the company's business. The new trading symbol for...

Company slated to join Russell 3000 Index.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Cepheid (CPHD) joined the Russell 3000 Index when the broad-market index was reconstituted June 30, according to a preliminary list of additions issued by Frank Russell Company. Index membership...

GeneXpert system receives R&D 100 award for technology innovation.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Cepheid (CPHD) announced that its GeneXpert fully automated gene analysis system has been selected to receive Research & Development (R&D) Magazine's "R&D 100 Award," honoring the year's 100 most...

Three new officers appointed to management team.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Comprehensive NeuroScience, Inc., (CNS) announced the appointment of James C. Ballenger, MD, and J.B. Goss, PhD, to senior vice president, and Regina Reale to vice president. James C. Ballenger will...

New partner sought to pursue treatment opportunity.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Cortex Pharmaceuticals, Inc., (COR), announced that Shire Pharmaceuticals Group plc has decided not to exercise its option to develop Cortex's Ampakine technology and compounds for the treatment of...

Company corrects June 24 press release.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- CryoLife, Inc., (CRY), a life-science company involved in the development and commercialization of cryopreserved and tissue-engineered implantable heart valves, vascular, and orthopedic grafts, and...

Preliminary second quarter results released.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Curon Medical, Inc., (CURN) a provider of innovative proprietary products for the treatment of gastrointestinal disorders, announced preliminary financial results for the second quarter ended June 30,...

Sankyo Increases milestone payments to $25 million for GlucoWatch Biographer.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Cygnus, Inc., (CYGN) and Sankyo Pharma, Inc., a wholly owned subsidiary of Sankyo Co., Ltd., announced that Sankyo Pharma Inc. will make additional milestone payments of $15 million to Cygnus, Inc.,...

Company restructures joint ventures, operations.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- DOR BioPharma, Inc., (DOR) announced that it has restructured its two joint ventures with Elan Corporation, plc and its affiliated companies effective June 29, 2002, and implemented a further fixed...

Dako, Cytomation to join forces.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Dako A/S, the world's leading producer of cancer diagnostic reagents, and the Colorado-based bioinstrumentation company, Cytomation, Inc., merged on July 1. With the merger, Dako and Cytomation will...

Bank financing of up to $25M secured.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Deltagen, Inc., (DGEN) announced the company's signing of two new financing agreements. The agreements include a $20 million term loan and a 1-year $5 million accounts receivable loan. The...

Merger agreement with Cytyc terminated.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Digene Corporation (DIGE) announced that on Sunday, June 30, 2002, Digene delivered to Cytyc Corporation (CYTC) formal notice of Digene's termination of the Merger Agreement dated February 19, 2002,...

Investment services expert named to board of directors.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Dimethaid Research, Inc., (TSX: DMX) announced the appointment of Brian E. Walsh to its board of directors. At the same time, the company announced it has received gross proceeds of CDN$1 million...

Lukas Braunschweiler named president, CEO.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Dionex Corporation (DNEX) announced that Lukas Braunschweiler, PhD will become its president and CEO, effective August 5, 2002. A. Blaine Bowman, who has been serving as president and CEO since 1980,...

Company announces record-setting year-end revenues.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- DrugMax, Inc., (DMAX) filed its Form 10-KSB and announced financial results for the fourth quarter and fiscal year ended March 31, 2002. For the fiscal year ended March 31, 2002, total revenues...

Revenue increases 1157%.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Elite Pharmaceuticals, Inc., (ELI) reported financial results for the year ended March 31, 2002. Elite's revenues for the year ended March 31, 2002 were $1.2 million, compared with $0.1 million in...

Letter of intent signed with U.K. group.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Endovasc, Ltd., Inc., (ENDV; ED7) announced that it had signed a binding letter of intent with a group of investors in London to establish an affiliated company that will help finance the company's...

Licensing agreement focuses on cancer vaccines.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN), a biotechnology company focused on the development of pharmaceutical products using multiple, specific epitopes to activate the body's immune system, announced that it had...

Escalon Medical Corp. announces departure of chief operating officer.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Escalon Medical Corp. (ESMC) announced that in conjunction with the expiration of his employment contract (June 30, 2002), Ronald L. Hueneke, president and chief operating officer has left the company...

LeadScope Enterprise licensed to German company for drug discovery.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- LeadScope, Inc., announced that Evotec OAI AG, Hamburg, Germany (EVT), has licensed LeadScope Enterprise and its Toxicity Content Module for use in its drug discovery process. "Evotec OAI is...

Anthony P. Adamis to lead research team.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Eyetech Pharmaceuticals, Inc., a privately held biotechnology company dedicated to the development and commercialization of novel drugs for the treatment of eye disease, announced that Harvard Medical...

Industry veteran named as VP of operations.
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Favrille, Inc., announced the appointment of Richard Murawski to its executive staff as senior vice president of operations. "Rich brings more than 31 years of manufacturing experience to Favrille...